Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rong‐Bo Lin"'
Autor:
Feng‐Hua Wang, Xiao‐Tian Zhang, Lei Tang, Qi Wu, Mu‐Yan Cai, Yuan‐Fang Li, Xiu‐Juan Qu, Hong Qiu, Yu‐Jing Zhang, Jie‐Er Ying, Jun Zhang, Ling‐Yu Sun, Rong‐Bo Lin, Chang Wang, Hao Liu, Miao‐Zhen Qiu, Wen‐Long Guan, Sheng‐Xiang Rao, Jia‐Fu Ji, Yan Xin, Wei‐Qi Sheng, Hui‐Mian Xu, Zhi‐Wei Zhou, Ai‐Ping Zhou, Jing Jin, Xiang‐Lin Yuan, Feng Bi, Tian‐Shu Liu, Han Liang, Yan‐Qiao Zhang, Guo‐Xin Li, Jun Liang, Bao‐Rui Liu, Lin Shen, Jin Li, Rui‐Hua Xu
Publikováno v:
Cancer Communications, Vol 44, Iss 1, Pp 127-172 (2024)
Abstract The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting the latest advancements in evidence‐based medicine, heal
Externí odkaz:
https://doaj.org/article/ddb71d41f751472a92fb64e883303e66
Autor:
Feng‐Hua Wang, Xiao‐Tian Zhang, Yuan‐Fang Li, Lei Tang, Xiu‐Juan Qu, Jie‐Er Ying, Jun Zhang, Ling‐Yu Sun, Rong‐Bo Lin, Hong Qiu, Chang Wang, Miao‐Zhen Qiu, Mu‐Yan Cai, Qi Wu, Hao Liu, Wen‐Long Guan, Ai‐Ping Zhou, Yu‐Jing Zhang, Tian‐Shu Liu, Feng Bi, Xiang‐Lin Yuan, Sheng‐Xiang Rao, Yan Xin, Wei‐Qi Sheng, Hui‐Mian Xu, Guo‐Xin Li, Jia‐Fu Ji, Zhi‐Wei Zhou, Han Liang, Yan‐Qiao Zhang, Jing Jin, Lin Shen, Jin Li, Rui‐Hua Xu
Publikováno v:
Cancer Communications, Vol 41, Iss 8, Pp 747-795 (2021)
Abstract There exist differences in the epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selections between gastric cancer patients from the Eastern and Western countries. T
Externí odkaz:
https://doaj.org/article/25078e83af624f808e27aec19309390f
Autor:
You-cai Zhu, Hong Wang, Xin Liu, Rong-bo Lin, Mei‐yu Fang, Xiao-jia Wang, Liping Wang, Yinbin Zhang, Bing Wan, Tangfeng Lv, Xiuyu Cai, Li Lin, Yong Song, Xingxiang Pu, Shi-jie Lan, Xin Cai, Chunwei Xu, Wenxian Wang, Lei Lei, Wu Zhuang, Yong Fang, Gang Chen, Zongyang Yu, Jinluan Li, Zi-yan Yang, Xian-bin Liang
Publikováno v:
Cancer Research. 80:38-38
Background: NTRK gene fusions involving either NTRK1, NTRK2 or NTRK3 are oncogenic drivers of various solid tumor types but generally at a low frequency. TRK inhibitors such as LOXO-101, entrectinib, X396, AB-106, TL118 had remarkable and durable ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d8997061a0b3619654325468ca4088c
https://doi.org/10.1158/1538-7445.am2020-38
https://doi.org/10.1158/1538-7445.am2020-38
Publikováno v:
Tumori. 100(5)
Peritoneal metastasis (PM) in patients with advanced gastric cancer (AGC) is a poor prognostic indicator. The aim of this study was to compare the response of AGC patients with PM to paclitaxel-based systemic multidrug chemotherapy with and without a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::622c8b51c775d35316742a4eff99415a
https://pubmed.ncbi.nlm.nih.gov/25343556
https://pubmed.ncbi.nlm.nih.gov/25343556